首页|经颅直流电刺激联合舍曲林对抑郁患者认知功能、神经递质水平及睡眠状况的影响

经颅直流电刺激联合舍曲林对抑郁患者认知功能、神经递质水平及睡眠状况的影响

扫码查看
目的:探讨经颅直流电刺激(Transcranial direct current stimulation,tDCS)联合舍曲林对抑郁(Major depressive disorder,MDD)患者的治疗效果.方法:将 2020 年 1 月至 2023 年6 月收治的MDD患者 84 例纳入研究,按照随机单双号分为药物组(单号)与联合tDCS组(双号)各 42 例,药物组采用盐酸舍曲林片与伪刺激治疗,联合tDCS 组采用盐酸舍曲林片联合 tDCS 治疗.比较两组治疗效果,治疗前后抑郁程度[认知扭曲问卷(Cognition distortions questiosaire,CDQ)、汉密尔顿抑郁量表(Hamilton depression scale,HAMD-17)]、认知功能[数字划销测验(Cancellation Test,NCT)、威斯康星卡片分类测验(Wisconsin card sorting test,WCST)]、神经递质水平[γ-氨基丁酸(γ-aminobutyric acid,GABA)、去甲肾上腺素(Norepinephrine,NE)、五羟色胺(5-Hydroxytryptamine,5-HT)和多巴胺(Dopamine,DA)]和睡眠状况[阿森斯失眠量表(Athens insomnia scale,AIS)、匹兹堡睡眠质量指数(Pittsburgh Sleep Quality Index,PSQI)]变化.结果:联合tDCS组治疗有效率(88.10%)显著高于药物组(69.05%)(P<0.05);治疗后,联合tDCS组CDQ评分、HAMD-17 评分、AIS和PSQI评分低于药物组(P<0.05),NCT 正确个数、净分、WCST 总应答数、正确应答数和完成分类数高于药物组(P<0.05),NCT 错误个数、漏划个数和WCST持续性错误数低于药物组(P<0.05);联合tDCS组GABA、NE、5-HT和DA水平显著高于药物组(P<0.05).结论:tDCS 联合舍曲林能有效缓解 MDD 患者抑郁症状,提升认知功能、神经递质水平,改善睡眠状况.
Effects of transcranial direct current stimulation combined with sertraline on cognitive function,neurotransmitter levels and sleep status in depressed patients
Objective:To investigate the efficacy of Transcranial direct current stimulation(tDCS)combined with sertraline in the treatment of patients with Major depressive disorder(MDD).Methods:84 MDD patients admitted from January 2020 to June 2023 were included in the study,and were randomly divided into drug group(single number)and combined tDCS group(even number)with 42 cases each,the drug group was treated with sertraline hydrochloride tablets and pseudo-stimulation,and the combined tDCS group was treated with Sertraline hydrochloride tablets and tDCS.Comparing the treatment effect between the two groups,The degree of depression before and after treatment[Cognition distortions questiosaire(CDQ),Hamilton depression scale(HAMD-17),cognitive function[Cancellation Test(NCT),Wisconsin card sorting test(WCST),neurotransmitter levels[gamma-Aminobutyric acid,GABA),Norepinephrine(NE),5-hydroxytryptamine(5-HT)and dopamine(DA),and sleep status[Athens insomnia scale,AIS),Pittsburgh sleep quality index(PSQI)].Results:The effective rate of combined tDCS group(88.10%)was significantly higher than that of drug group(69.05%)(P<0.05).After treatment,the CDQ scores,HAMD-17 scores,AIS and PSQI scores in combined tDCS group were lower than those in drug group(P<0.05),and the correct number of NCT,net score,total WCST responses,correct number of responses and completed classification numbers were higher than those in drug group(P<0.05).The number of NCT errors,missed marks and persistent errors of WCST were lower than those of drug group(P<0.05).The levels of GABA,NE,5-HT and DA in combined tDCS group were significantly higher than those in drug group(P<0.05).Conclusion:tDCS combined with sertraline can effectively alleviate depressive symptoms in MDD patients,improve cognitive function,neurotransmitter levels,and improve sleep status.

DepressionTranscranial direct current stimulationSertralineCognitive functionNeurotransmitter levelsSleep status

邓凡、彭智勇、付莲花、涂军

展开 >

宜春市第三人民医院精神心理科,江西 宜春 336000

宜春市第三人民医院检验科,江西 宜春 336000

抑郁 经颅直流电刺激 舍曲林 认知功能 神经递质水平 睡眠状况

2024

四川生理科学杂志
四川省生理科学会

四川生理科学杂志

影响因子:0.575
ISSN:1671-3885
年,卷(期):2024.46(6)